-
Superbugs Win Another Round As Big Pharma Leaves Antibiotics
Bloomberg | The fight against life-threatening infections suffered another blow when one of the world's biggest drugmakers waved the white flag. Novartis is the latest drug giant to end antibacterial and antiviral research, joining the like of AstraZeneca, Sanofi, and Allergan.
Jul 13, 2018
-
I'm Adopted, Should I Have DNA Testing?
Forbes | Should adoptees, or parents of adoptees, consider direct-to-consumer genetic testing kits to gain more information on health risks, ancestry, or to find biological relatives? A certified genetic counselor reviews the pros and cons you should know before you spit.
Jul 11, 2018
-
BioIVT Acquires Optivia, Adding Transporter Assay Products And Services To Its ADME-Tox Portfolio
Bio-IT World Brief | BioIVT today announced that it has acquired Santa Clara, CA-based Optivia and its comprehensive portfolio of transporter assays, multi-transporter models, transporter systems biology, and molecular transport research solutions.
Jul 9, 2018
-
JUWELS Becomes Germany’s Most Powerful Supercomputer
TOP500 | The first module of JUWELS, a supercomputer that is expected to be a model for future exascale systems, is now up and running at the Jülich Supercomputing Centre in Germany.
Jul 5, 2018
-
Why Data Science Is An Art – And How To Support The People Who Do It
Elsevier Connect | In his recent talk at the Bio-IT World Conference, Elsevier’s Jabe Wilson used examples of data science undertaken at Elsevier to illustrate why data science is an art – and how best to support data scientists based on this insight.
Jul 3, 2018
-
Match Cutting-Edge Research With Next Generation Data Solutions
Bio-IT World Contributed Commentary | With data emerging as the undisputed driver for 21st Century medicine, it is becoming clear that we cannot expect to design our next generation data infrastructure on the technologies of the last century—technologies that were never intended to handle today’s extreme data volume and workloads.
Jul 2, 2018
-
From Discovery To Trials In 18 Months: MD Anderson’s Therapeutics Discovery Team Approach
Bio-IT World | At MD Anderson, the Therapeutics Discovery team aims to develop new treatment options for MD Anderson patients in a much faster way. Two studies published in Nature Medicine earlier this month support the approach, they say.
Jun 29, 2018
-
Helix Announces Expansion Of Its Executive Team, New Denver Office
Bio-IT World Brief | Helix today announced a new CFO, CMO, and CPO, coupled with the acquisition of Denver-based HumanCode.
Jun 28, 2018
-
Deloitte, PerkinElmer, iRODS, And More: News From June 2018
Bio-IT World | June featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Deloitte, PerkinElmer, iRODS, and more.
Jun 27, 2018
-
DDN Announces A3I Solutions: Parallel Data Platforms For AI
Bio-IT World Brief | DataDirect Networks today announced a set of data platforms for artificial intelligence and deep learning. Engineered for the AI data center, DDN’s A3I solutions are optimized to handle the spectrum of AI activities concurrently from data ingest and preparation to training, validation and inference.
Jun 26, 2018
-
Deep Learning Tool Empowers Biologists, Speeds Screening
Bio-IT World | Traditional high content screening is labor- and time-intensive, and many groups are working to apply deep learning to image analysis. Genedata worked with AstraZeneca to validate a deep learning workflow tool for biologists that can be “unsupervised”—it works without re-engineering across different assay types and settings.
Jun 25, 2018
-
Challenges In Bringing Personalized Cancer Vaccines To The Clinic
Bio-IT World Contributed Commentary | The cancer vaccine industry faces a challenge: How to transition from prediction to effective vaccine therapy?
Jun 21, 2018
-
Alexion’s Quest To Test The Algorithm Of Rare Disease Diagnosis
Bio-IT World | Alexion, in collaboration with EPAM, has developed a software competition platform to allow the objective comparison of contributed algorithms for automated rare disease diagnosis.
Jun 20, 2018
-
Roche Pays $2.4 Billion For Rest Of Cancer Expert Foundation Medicine
Reuters | Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine, raising its bet on the U.S. genomic profiling group's ability to personalize cancer care.
Jun 19, 2018
-
Celgene’s LabAlert System Focuses On Scientific Workflow Efficiency, User Experience
Bio-IT World | Innovative mobile technology that quickly sends warnings and error notifications to users’ mobile devices won a Bio-IT World 2018 Best Practices Award. The Celgene Lab Instrument Mobile Alert (LabAlert) system integrates into the laboratory environment to generate, manage, and report real-time alerts from lab instruments to mobile devices.
Jun 18, 2018
-
Benchling Raises $14.5M From Benchmark To Advance Life Sciences Research
Bio-IT World Brief | Today Benchling announced it has closed $14.5M in Series B funding led by Benchmark, with participation from F-Prime Capital and returning investor Thrive Capital.
Jun 14, 2018
-
Archive First, For The Future
Bio-IT World Contributed Commentary | The life sciences industry has continually experienced one innovation after another that multiples the amount of data being generated, outpacing enterprise IT. It’s crucial for life sciences IT to invest in the right infrastructure now, to manage their growing data and prepare for the future.
Jun 13, 2018
-
Move Over China: U.S. Is Again Home To World’s Speediest Supercomputer
The New York Times | For the past five years, China has had the world's fastest computer. But as of Friday, Summit, a machine built in the United States, is taking the lead.
Jun 12, 2018
-
NeuroBANK Banking On Collaboration, Compassion, Clinical Research
Bio-IT World | A Harvard professor and Bio-IT World 2018 Best Practices Award winner is banking on old-fashioned collaboration and compassion, along with 21st century technology, to help principal investigators collect data for clinical research and to facilitate the development of new therapies and cures.
Jun 12, 2018
-
All The Gear But Still No Idea? Why Machines Alone Can’t Cure Cancer
Bio-IT World Contributed Commentary | Despite the hype and fanfare that has accompanied massive supercomputers and AI platforms in recent years, there is still no tool capable of delivering answers to questions such as, “How do I cure a particular patient’s type of cancer?”
Jun 11, 2018